相关实验视频
Updated: Jun 24, 2025

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
338
关于肺栓塞的简短历史视角
Clinton T Morgan1, Sibu P Saha1
1Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky, Lexington, Kentucky.
概括
自1800年代以来,肺栓塞 (PE) 诊断和治疗已经显著发展. 现代方法整合了先进的成像,抗凝固和多学科团队,以改善患者的治疗结果.
科学领域:
- 医学史 医学史 医学史
- 心血管医学 心血管医学
- 肺部医学 肺部医学
背景情况:
- 肺栓塞 (PE) 是全球死亡的一个重要原因.
- 了解PE的病理生理学始于19世纪的Virchow.
研究的目的:
- 提供关于肺栓塞的历史视角.
- 追踪PE诊断和治疗的演变.
主要方法:
- 医学文献和进展的历史审查.
- 追踪诊断和干预技术的发展.
主要成果:
- 早期的干预包括手术栓塞切除和结.
- 进步导致了下腔静脉过器,抗凝固和心肺绕道.
- 诊断能力从基本的监测演变为先进的成像,如CT血管造影.
结论:
- 目前的PE管理涉及复杂的诊断,分类和各种治疗.
- 肺栓塞反应小组指导当代治疗策略.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
169
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
169
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pneumonia I: Introduction
221
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
221
Pneumonia III: Complications and Assessment
200
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
200
Pneumothorax-I
195
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
195
Pneumothorax-II
139
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
139

